🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immunocompromised individuals, such as solid organ transplant (SOT) recipie...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2021-09-24
Trial ID
NCT05060991
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
1. Study Design This is a single-center, prospective, randomized, controlle...
Status
Recruiting
Location
Clinical Research Ethics Committee of the General Hospital of Eastern Theater Command of the People's Liberation Army
Start Date
2025-12-08
Trial ID
NCT07340463
Treatments Being Tested
Rationale: The combination of azathioprine and prednisone is the first-line...
Status
Unknown
Location
Jeroen Bosch Ziekenhuis
Start Date
2022-01-19
Trial ID
NCT05221411
Treatments Being Tested
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
RATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophospham...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-07-28
Trial ID
NCT00309842
The goal of this clinical research study is to learn if it is safe and feas...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-07-13
Trial ID
NCT01471067
The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Status
Terminated
Location
University of Alabama
Start Date
2011-09
Trial ID
NCT01436305
Treatments Being Tested
This study introduces a new optimization immunosuppressive regimen associat...
Status
Completed
Location
Novartis
Start Date
2005-12
Trial ID
NCT00284934
Treatments Being Tested
This study will evaluate the efficacy and safety of LCP-Tacro (tacrolimus) ...
Status
Completed
Location
Clinical Site 1020
Start Date
2010-09
Trial ID
NCT01187953
Treatments Being Tested